Docetaxel Actavis 20mg/0.5ml

Docetaxel 20mg/0.5ml

Category:

Description

Docetaxel 20mg/0.5ml

Docetaxel Actavis 20mg/0.5ml in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:

  • operable node- positive breast cancer
  • operable node- negative breast cancer

For patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer

Docetaxel Actavis 20mg/0.5ml